Search

Your search keyword '"Hoke M"' showing total 421 results

Search Constraints

Start Over You searched for: Author "Hoke M" Remove constraint Author: "Hoke M"
421 results on '"Hoke M"'

Search Results

153. SNDR sensitivity analysis for cascaded ΣΔ modulators

160. A randomized, double-blind, Phase 1, single- and multiple-dose placebo-controlled study of the safety and pharmacokinetics of IN-006, an inhaled antibody treatment for COVID-19 in healthy volunteers.

161. Combined clinical, structural and cellular studies discriminate pathogenic and benign TRPV4 variants.

162. TRPV4 neuromuscular disease registry highlights bulbar, skeletal and proximal limb manifestations.

163. Vitamin D levels do not correlate with severity of idiopathic peripheral neuropathy.

164. Combined Effects of Clonal Hematopoiesis and Carotid Stenosis on Cardiovascular Mortality.

165. TREM2 protects from atherosclerosis by limiting necrotic core formation.

166. The COVID-19 pandemic and the experience of postpartum depression.

167. ZB-06, a vaginal film containing an engineered human contraceptive antibody (HC4-N), demonstrates safety and efficacy in a phase 1 postcoital test and safety study.

168. Metabolomics implicate eicosanoids in severe functional mitral regurgitation.

169. APRIL limits atherosclerosis by binding to heparan sulfate proteoglycans.

170. Transient Heart Failure Followed by Claudication of the Lower Limbs Due to Takayasu Vasculitis With Concomitant Myositis.

171. Relative contributions of urine sulfate, titratable urine anion, and GI anion to net acid load and effects of age.

172. Disparate effects of adalimumab and fumaric acid esters on cardiovascular risk factors in psoriasis patients: results from a prospective, randomized, observer-blinded head-to-head trial.

173. Impact of exercise on bone mineral density, fall prevention, and vertebral fragility fractures in postmenopausal osteoporotic women.

174. The novel immunomodulatory biologic LMWF5A for pharmacological attenuation of the "cytokine storm" in COVID-19 patients: a hypothesis.

175. Von Willebrand factor antigen levels predict major adverse cardiovascular events in patients with carotid stenosis of the ICARAS study.

176. Carotid ultrasound investigation as a prognostic tool for patients with diabetes mellitus.

177. Bladder Pain Syndrome.

178. The prognostic value of serum amyloid A for long-term mortality among patients with subclinical carotid atherosclerosis.

179. Large vessel vasculitis in Behçet's disease.

181. Combined Effects of Inflammatory Status and Carotid Atherosclerosis: A 12-Year Follow-Up Study.

182. Anti-Müllerian Hormone Signaling Regulates Epithelial Plasticity and Chemoresistance in Lung Cancer.

183. Percutaneous instillation of physiological saline solution for the treatment of femoral pseudoaneuryms.

184. Red cell distribution width and mortality in carotid atherosclerosis.

185. The impact of selectins on mortality in stable carotid atherosclerosis.

186. The impact of uric acid on long-term mortality in patients with asymptomatic carotid atherosclerotic disease.

187. Dark chocolate and vascular function in patients with peripheral artery disease: a randomized, controlled cross-over trial.

189. Mean platelet volume predicts outcome in patients with asymptomatic carotid artery disease.

190. Prognostic value of neutrophils in patients with asymptomatic carotid artery disease.

191. Do environments in infancy moderate the association between stress and inflammation in adulthood? Initial evidence from a birth cohort in the Philippines.

192. Solid phase detection of C4d-fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipients.

193. A validated risk score to predict outcomes after carotid stenting.

194. Usefulness of hemoglobin level to predict long-term mortality in patients with asymptomatic carotid narrowing by ultrasonography.

195. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.

196. Polymorphism of the complement 5 gene and cardiovascular outcome in patients with atherosclerosis.

197. Relative importance of different lipid risk factors for the development of myocardial infarction at a very young age (≤ 40 years of age).

198. Renal function and long-term mortality in patients with asymptomatic carotid atherosclerosis.

199. The prognostic impact of soluble apoptosis-stimulating fragment on mortality in patients with carotid atherosclerosis.

200. Beta 2 microglobulin and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis.

Catalog

Books, media, physical & digital resources